Cardiology Medical News about virus-negative inflammatory cardiomyopathy;efficacy of immunosuppressive therapy

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death

3. The Job Market for 2008-2009: Compensation

4. Renal Artery Stenosis

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: The TIMIC study
European Heart Journal, 06/30/09

Frustaci A et al. – Data confirm the efficacy of immunosuppression in virus-negative inflammatory cardiomyopathy. Lack of response in 12% of cases suggests presence of un-screened viruses or mechanisms of damage and inflammation not susceptible to immunosuppression.

Methods

Randomized, double-blind, placebo-controlled study of the efficacy of immunosuppression in virus-negative inflammatory cardiomyopathy
Subjects: 85 pts with myocarditis and chronic (>6 mo) heart failure unresponsive to conventional therapy, with no evidence of myocardial viral genomes
Administration of either prednisone or placebo, plus conventional therapy for heart failure
Group 1 (43 pts): prednisone 1 mg kg–1 day–1 for 4 wks; then 0.33 mg kg–1 day–1 for 5 mo and azathioprine 2 mg kg–1 day–1 for 6 mo
Group 2 (42 pts): placebo
Primary outcome: 6 mo improvement in left-ventricular function

Results

Group 1: significant improvement of left-ventricular ejection fraction and significant decrease in left-ventricular dimensions and volumes vs baseline
Group 2: no improvement of ejection fraction; significantly worsened vs baseline
No major adverse reaction due to immunosuppression

<< Previous
Delayed neutrophil apoptosis in patients with unstable angina:...

Next >>
Myocardial microvascular function during acute coronary artery...